The Enterprise Value as of December 2025 (TTM) for Suven Pharmaceuticals Limited (SUVENPHAR.NS) is 414.34B

According to Suven Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 414.34B. This represents a change of 55.03% compared to the average of 267.26B of the last 4 quarters.

Suven Pharmaceuticals Limited (SUVENPHAR.NS) Historical Enterprise Value (quarterly & annually)

How has SUVENPHAR.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Suven Pharmaceuticals Limited over the last ten years is 131.42B. The current 414.34B Enterprise Value has changed 31.43% with respect to the historical average. Over the past ten years (40 quarters), SUVENPHAR.NS's Enterprise Value was at its highest in in the September 2024 quarter at 297.74B. The Enterprise Value was at its lowest in in the December 2018 quarter at 0.

Suven Pharmaceuticals Limited (SUVENPHAR.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Suven Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Suven Pharmaceuticals Limited (SUVENPHAR.NS) Average Enterprise Value

How has SUVENPHAR.NS Enterprise Value performed in the past?

The current Enterprise Value of Suven Pharmaceuticals Limited (SUVENPHAR.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Suven Pharmaceuticals Limited (SUVENPHAR.NS) Enterprise Value vs. Peers

How is SUVENPHAR.NS’s Enterprise Value compared to its peers?

Suven Pharmaceuticals Limited’s Enterprise Value is greater than Glenmark Life Sciences Limited (128.77B), greater than Glenmark Life Sciences Limited (128.77B), greater than Caplin Point Laboratories Limited (107.63B), greater than Novartis India Limited (13.35B), greater than Vivimed Labs Ltd. (5.85B), greater than Lincoln Pharmaceuticals Limited (12.73B), greater than Bafna Pharmaceuticals Limited (393.64M), greater than Ind-Swift Limited (8.90B), greater than Ind-Swift Limited (8.90B), greater than Ortin Laboratories Limited (159.91M),

Build a custom stock screener for Suven Pharmaceuticals Limited (SUVENPHAR.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Suven Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Suven Pharmaceuticals Limited (SUVENPHAR.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Suven Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.